The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy
Abstract
Although anti-PD-1 immunotherapy is widely used to treat melanoma, its efficacy still has to be improved. In this work, we present a therapeutic method that combines immunotherapy and starvation therapy to achieve better antitumor efficacy. We designed the CMSN-GOx method, in which mesoporous silica nanoparticles (MSN) are loaded with glucose oxidase (GOx) and then encapsulate the surfaces of cancer cell membranes to realize starvation therapy. By functionalizing the MSN's biomimetic surfaces, we can synthesize nanoparticles that can escape the host immune system and homologous target. These attributes enable the nanoparticles to have improved cancer targeting ability and enrichment in tumor tissues. Our synthetic CMSN-GOx complex can ablate tumors and induce dendritic cell maturity to stimulate an antitumor immune response. We performed an in vivo analysis of these nanoparticles and determined that our combined therapy CMSN-GOx plus PD-1 exhibits a better antitumor therapeutic effect than therapies using CMSN-GOx or PD-1 alone. Additionally, we used the positron emission tomography imaging to measuring the level of glucose metabolism in tumor tissues, for which we investigate the effect with the cancer therapy in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Research works printed but not linked: 40
- 10.1016/j.ccell.2015.03.001 · DOI · Paper page
- 10.1016/j.nantod.2015.06.007 · DOI
- 10.1073/pnas.1508516112 · DOI
- 10.1016/j.copbio.2016.02.001 · DOI
- 10.1126/science.aaa8172 · DOI · Paper page
- 10.1016/j.cell.2015.03.030 · DOI · Paper page
- 10.1038/nrclinonc.2015.237 · DOI
- 10.1093/annonc/mdv383 · DOI · Paper page
- 10.2337/dc15-0889 · DOI
- 10.1016/j.coi.2013.02.009 · DOI · Paper page
- 10.1158/1078-0432.CCR-15-1507 · DOI · Paper page
- 10.1038/nature14211 · DOI
- 10.1021/acs.nanolett.5b05030 · DOI · Paper page
- 10.1038/ncomms13193 · DOI · Paper page
- 10.1038/s41467-017-01050-0 · DOI · Paper page
- 10.1002/adma.201402996 · DOI · Paper page
- 10.1021/jacs.6b06663 · DOI · Paper page
- 10.1021/jacs.6b09538 · DOI · Paper page
- 10.1021/acsnano.6b04989 · DOI · Paper page
- 10.1021/acsnano.7b02533 · DOI · Paper page
- 10.1038/s41467-017-00424-8 · DOI · Paper page
- 10.1002/anie.201706964 · DOI · Paper page
- 10.1002/anie.201610682 · DOI · Paper page
- 10.1021/acs.nanolett.7b01382 · DOI · Paper page
- 10.1021/acsnano.7b00905 · DOI · Paper page
- 10.1038/natrevmats.2016.14 · DOI · Paper page
- 10.1016/j.addr.2009.11.004 · DOI · Paper page
- 10.1002/smll.201502388 · DOI · Paper page
- 10.1021/acsnano.7b00133 · DOI · Paper page
- 10.1002/adfm.201604774 · DOI · Paper page
- 10.1021/nn501040h · DOI · Paper page
- 10.1002/adma.201506086 · DOI · Paper page
- 10.1021/nl500618u · DOI · Paper page
- 10.1146/annurev.immunol.21.120601.141135 · DOI · Paper page
- Deng W. W., 2016, Am. J. Transl. Res., 8, 3387
- 10.1002/adma.201605604 · DOI
- 10.1021/ar500362y · DOI · Paper page
- 10.2967/jnumed.107.045922 · DOI · Paper page
- 10.1016/0092-8674(94)90335-2 · DOI · Paper page
- 10.1084/jem.20021328 · DOI · Paper page
Cited by
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
Chang, M., Wang, M., Wang, M., Shu, M., Ding, B., Li, C., Pang, M., Cui, S., Hou, Z., & Lin, J. (2019) · Advanced Materials · doi:10.1002/adma.201905271 · Cited by 484
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202004788 · Cited by 450
Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles
Liu, L., Bai, X., Martikainen, M.-V., Kårlund, A., Roponen, M., Xu, W., Hu, G., Tasciotti, E., & Lehto, V.-P. (2021) · Nature Communications · doi:10.1038/s41467-021-26052-x · Cited by 440
Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy
Jiang, Q., Wang, K., Zhang, X., Ouyang, B., Liu, H., Pang, Z., & Yang, W. (2020) · Small · doi:10.1002/smll.202001704 · Cited by 426
Metadata
- Authors
- Xie, W., Deng, W.-W., Zan, M., Rao, L., Yu, G.-T., Zhu, D.-M., Wu, W.-T., Chen, B., Ji, L.-W., Chen, L., Liu, K., Guo, S.-S., Huang, H.-M., Zhang, W.-F., Zhao, X., Yuan, Y., Dong, W., Sun, Z.-J., & Liu, W.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-02-25
- Volume
- 13
- Issue
- 3
- Pages
- 2849-2857
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2916790876
- Cited by
- 343
- References
- 3
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Funders
- National Natural Science Foundation of China (61722405, 81672668, 81527801, 61474084)
- Ministry of Education of the People's Republic of China (2016YFC1000700, 2042017kf0171)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.